Klaus K Herfarth Selected Research

Klaus K Herfarth Research Topics

10	Neoplasms (Cancer) 05/2015 - 06/2003
2	Adenoid Cystic Carcinoma (Cylindroma) 02/2015 - 11/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2011 - 06/2003
2	Carcinoma (Carcinomatosis) 04/2010 - 10/2009
2	Astrocytoma (Pilocytic Astrocytoma) 04/2004 - 11/2002
1	Neurofibrosarcoma (MPNST) 05/2015
1	Chondrosarcoma 05/2014
1	Prostatic Neoplasms (Prostate Cancer) 09/2013
1	Neoplasm Metastasis (Metastasis) 07/2013
1	Ovarian Neoplasms (Ovarian Cancer) 04/2010
1	AIDS-Related Complex (ARC) 10/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2009
1	Anus Neoplasms (Anal Cancer) 10/2009
1	Brain Neoplasms (Brain Tumor) 02/2009
1	Sarcoma (Soft Tissue Sarcoma) 11/2008
1	Malignant Mesothelioma 02/2008
1	Cysts 11/2002
1	Craniopharyngioma (Craniopharyngiomas) 11/2002
1	Radiation Injuries (Radiation Sickness) 11/2002
1	Chordoma 01/2002

4	CarbonIBA 05/2015 - 11/2011
2	Protons (Proton)IBA 05/2014 - 04/2004
2	Tyrosine (L-Tyrosine)FDA Link 04/2004 - 11/2002
1	IonsIBA 05/2014
1	HydrogelsIBA 09/2013
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2013
1	Cetuximab (Erbitux)FDA Link 07/2011
1	Carboplatin (JM8)FDA LinkGeneric 04/2010
1	taxaneIBA 04/2010
1	Cisplatin (Platino)FDA LinkGeneric 02/2008
1	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 03/2007
1	Amifostine (Ethyol)FDA LinkGeneric 03/2007
1	Amino Acids FDA Link 04/2004
1	Gadolinium DTPA (Magnevist)FDA Link 11/2002

14	Radiotherapy 09/2013 - 01/2002
8	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2013 - 01/2002
5	Therapeutics 07/2013 - 01/2002
3	Heavy Ion Radiotherapy 02/2015 - 11/2011
2	Re-Irradiation 02/2015 - 02/2009
2	Drug Therapy (Chemotherapy) 02/2015 - 04/2010
1	Drug Tapering 09/2013
1	Radioimmunotherapy 07/2011
1	Adjuvant Chemotherapy 04/2010
1	Neoadjuvant Therapy 02/2008
1	Pneumonectomy (Lung Volume Reduction) 02/2008
1	Adjuvant Radiotherapy 02/2008
1	Conformal Radiotherapy 01/2002